J E Westlin

664 total citations
18 papers, 514 citations indexed

About

J E Westlin is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J E Westlin has authored 18 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J E Westlin's work include Neuroendocrine Tumor Research Advances (9 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Neuroblastoma Research and Treatments (4 papers). J E Westlin is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Neuroblastoma Research and Treatments (4 papers). J E Westlin collaborates with scholars based in Sweden. J E Westlin's co-authors include Håkan Åhlström, Bengt Långström, T. Jansson, Anders Lilja, Jonas Bergh, Karl Mikael Kälkner, Kjell Öberg, Eva Tiensuu Janson, Sten Nilsson and W. Graf and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and European Journal of Endocrinology.

In The Last Decade

J E Westlin

18 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J E Westlin Sweden	9	230	215	182	121	121	18	514
Zeynep Gözde Özkan Türkiye	14	243 1.1×	217 1.0×	131 0.7×	68 0.6×	121 1.0×	40	518
Alexander Weich Germany	12	366 1.6×	160 0.7×	205 1.1×	132 1.1×	108 0.9×	48	582
Giancarlo Montini Italy	7	278 1.2×	160 0.7×	281 1.5×	280 2.3×	87 0.7×	8	537
Sheila Lindsay United States	12	189 0.8×	87 0.4×	136 0.7×	81 0.7×	36 0.3×	19	569
W.T. Knöfel Germany	7	196 0.9×	39 0.2×	93 0.5×	82 0.7×	168 1.4×	7	395
Vania Altrinetti Italy	15	52 0.2×	137 0.6×	78 0.4×	109 0.9×	73 0.6×	26	545
Isamu Hayashi Japan	12	173 0.8×	47 0.2×	74 0.4×	49 0.4×	212 1.8×	20	507
Katherine Yao United States	11	335 1.5×	44 0.2×	184 1.0×	128 1.1×	139 1.1×	16	618
Lisa Hazard United States	12	188 0.8×	33 0.2×	143 0.8×	57 0.5×	177 1.5×	19	423

Countries citing papers authored by J E Westlin

Since Specialization

Citations

This map shows the geographic impact of J E Westlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J E Westlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J E Westlin more than expected).

Fields of papers citing papers by J E Westlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J E Westlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J E Westlin. The network helps show where J E Westlin may publish in the future.

Co-authorship network of co-authors of J E Westlin

This figure shows the co-authorship network connecting the top 25 collaborators of J E Westlin. A scholar is included among the top collaborators of J E Westlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J E Westlin. J E Westlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Westlin, J E, et al.. (2005). Identification of sentinel nodes in patients with colon cancer. European Journal of Surgical Oncology. 31(4). 381–385. 23 indexed citations

Lundin, Evelyn Serreyn, Urban Karlbom, J E Westlin, et al.. (2004). Scintigraphic assessment of slow transit constipation with special reference to right‐ or left‐sided colonic delay. Colorectal Disease. 6(6). 499–505. 26 indexed citations

Fjällskog, Marie-Louise, Anders Sundin, J E Westlin, et al.. (2002). Treatment of Malignant Endocrine Pancreatic Tumors with a Combination of α-Interferon and Somatostatin Analogs. Medical Oncology. 19(1). 35–42. 57 indexed citations

Kälkner, Karl Mikael, J E Westlin, & Peter Strang. (2000). 89Strontium in the management of painful sceletal metastases.. PubMed. 20(2B). 1109–14. 4 indexed citations

Lennernäs, Bo, Hans Nordgren, A. Holmberg, et al.. (2000). Human milk fat globule antigen 1 (HMFG1) expression in prostatic carcinoma and immunotargeting with a radiolabelled monoclonal anti-HMFG1 antibody.. PubMed. 20(4). 2321–4. 3 indexed citations

Edgren, M, J E Westlin, Karl Mikael Kälkner, Anders Sundín, & S. Nilsson. (1999). [ ¹¹¹ In-DPTA-D-Phe ¹ ] - Octreotide Scintigraphy in the Management of Patients with Advanced Renal Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 14(1). 59–64. 24 indexed citations

Eriksson, Barbro, Håkan Örlefors, Anders Sundin, et al.. (1998). [PET in neuroendocrine tumors].. PubMed. 113(9). 308–12. 1 indexed citations

Wester, Kenneth, A. Holmberg, S. Nilsson, et al.. (1998). Expression of Epidermal Growth Factor Receptor in Urinary Bladder Cancer Metastases. The Journal of Urology. 160(5). 1937–1938. 1 indexed citations

Blomquist, Erik, Hans Bolander, Lars Gedda, et al.. (1998). Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials.. International Journal of Molecular Medicine. 1(4). 693–702. 5 indexed citations

10.

Kälkner, Karl Mikael, S. Nilsson, & J E Westlin. (1998). [111In-DTPA-D-Phe1]-octreotide scintigraphy in patients with hormone-refractory prostatic adenocarcinoma can predict therapy outcome with octreotide treatment: a pilot study.. PubMed. 18(1B). 513–6. 16 indexed citations

11.

Kälkner, Karl Mikael, et al.. (1997). Comparison between Transversal SPECT, 3-dimensional Rendering and 3-dimensional Rendering plus Clipping in the Diagnosis of Somatostatin Receptor Distribution in Malignancies using ¹¹¹ In-DTPA-D-Phe ¹ -octreotide Scintigraphy. Cancer Biotherapy and Radiopharmaceuticals. 12(2). 89–99. 1 indexed citations

12.

Jansson, T., J E Westlin, Håkan Åhlström, et al.. (1995). Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?. Journal of Clinical Oncology. 13(6). 1470–1477. 199 indexed citations

13.

Holmberg, A., Marcela Márquez, J E Westlin, & Sara C. Nilsson. (1995). Labeling of polypeptides with technetium-99m using a dextran spacer.. PubMed. 55(23 Suppl). 5710s–5713s. 7 indexed citations

14.

Nilsson, Sten, Jean Claude Reubi, Karl Mikael Kälkner, et al.. (1995). Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.. PubMed. 55(23 Suppl). 5805s–5810s. 52 indexed citations

15.

Kälkner, Karl Mikael, Eva Tiensuu Janson, Sten Nilsson, et al.. (1995). Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers.. PubMed. 55(23 Suppl). 5801s–5804s. 48 indexed citations

16.

Öhrvall, Ulf, J E Westlin, Sara C. Nilsson, et al.. (1995). Human biodistribution of [111In]diethylenetriaminepentaacetic acid-(DTPA)-D-[Phe1]-octreotide and peroperative detection of endocrine tumors.. PubMed. 55(23 Suppl). 5794s–5800s. 7 indexed citations

17.

Graf, W., et al.. (1994). Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study. International Journal of Colorectal Disease. 9(1). 35–39. 36 indexed citations

18.

Burman, Pia, et al.. (1993). Large somatostatin-insensitive thyrotrophin-secreting pituitary tumour responsive to d-thyroxine and dopamine agonists. European Journal of Endocrinology. 129(4). 291–295. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact